These 3 ASX shares just stormed to all-time highs: Can they go higher?

The AGL Energy Ltd (ASX:AGL) share price is one of three that have stormed to all-time highs. Here's why…

| More on:
a woman

You’re reading a free article with opinions that may differ from The Motley Fool’s Premium Investing Services. Become a Motley Fool member today to get instant access to our top analyst recommendations, in-depth research, investing resources, and more. Learn More

It has been a bit of a mixed week for the S&P/ASX 200 (Index: ^AXJO) (ASX: XJO). The benchmark index has had a number of ups and downs and finds itself trading just a touch higher than where it started week-to-date.

But that hasn't stopped the three shares below from storming to all-time highs. Here's why:

The AGL Energy Ltd (ASX: AGL) share price stormed to an all-time high of $26.91 during yesterday's trade. A solid half-year result, a new dividend policy, and rising wholesale electricity prices have all played a part in driving its shares higher. Although I think it is starting to look a little expensive now, I expect that it could climb higher after UBS upgraded its shares this morning to a buy rating with a $29.50 price target.

The National Veterinary Care Ltd (ASX: NVL) share price hit an all-time high of $2.65 on Thursday. Yesterday's gain means the veterinary service provider's shares have now climbed a massive 23% in 2017. A solid half-year result in February appears to have impressed many in the market. Especially Washington H. Soul Pattinson and Co. Ltd (ASX: SOL) which has just increased its stake in the company to 7.8%. Despite its shares being at an all-time high, I think National Veterinary Care would still be a great buy and hold investment today.

The Opthea Ltd (ASX: OPT) share price rocketed to a new high of $1.15 yesterday as investors continued to pile into the developer of novel biologic therapies for the treatment of eye diseases. The catalyst for this was the positive results from the Phase 1/2A clinical trial of its novel therapy OPT-302. Whilst there is still a lot of work to be done, the early progress the company has made is certainly very promising. For this reason I think its shares deserve a spot on your watch list.

Motley Fool contributor James Mickleboro has no position in any stocks mentioned. The Motley Fool Australia owns shares of Washington H. Soul Pattinson and Company Limited. We Fools may not all hold the same opinions, but we all believe that considering a diverse range of insights makes us better investors. The Motley Fool has a disclosure policy. This article contains general investment advice only (under AFSL 400691). Authorised by Bruce Jackson.

More on ⏸️ Investing

Close up of baby looking puzzled
Retail Shares

What has happened to the Baby Bunting (ASX:BBN) share price this year?

It's been a volatile year so far for the Aussie nursery retailer. We take a closer look

Read more »

woman holds sign saying 'we need change' at climate change protest
ETFs

3 ASX ETFs that invest in companies fighting climate change

If you want to shift some of your investments into more ethical companies, exchange-traded funds can offer a good option

Read more »

a jewellery store attendant stands at a cabinet displaying opulent necklaces and earrings featuring diamonds and precious stones.
⏸️ Investing

The Michael Hill (ASX: MHJ) share price poised for growth

Investors will be keeping an eye on the Michael Hill International Limited (ASX: MHJ) share price today. The keen interest…

Read more »

ASX shares buy unstoppable asx share price represented by man in superman cape pointing skyward
⏸️ Investing

The Atomos (ASX:AMS) share price is up 15% in a week

The Atomos (ASX: AMS) share price has surged 15% this week. Let's look at what's ahead as the company build…

Read more »

Two people in suits arm wrestle on a black and white chess board.
Retail Shares

How does the Temple & Webster (ASX:TPW) share price stack up against Nick Scali (ASX:NCK)?

How does the Temple & Webster (ASX: TPW) share price stack up against rival furniture retailer Nick Scali Limited (ASX:…

Read more »

A medical researcher works on a bichip, indicating share price movement in ASX tech companies
Healthcare Shares

The Aroa (ASX:ARX) share price has surged 60% since its IPO

The Aroa (ASX:ARX) share price has surged 60% since the Polynovo (ASX: PNV) competitor listed on the ASX in July.…

Read more »

asx investor daydreaming about US shares
⏸️ How to Invest

How to buy US shares from Australia right now

If you have been wondering how to buy US shares from Australia to gain exposure from the highly topical market,…

Read more »

⏸️ Investing

Why Fox (NASDAQ:FOX) might hurt News Corp (ASX:NWS) shareholders

News Corporation (ASX: NWS) might be facing some existential threats from its American cousins over the riots on 6 January

Read more »